Philippines proposes compulsory adoption of ASEAN CTD
This article was originally published in SRA
The Philippine pharmaceutical industry association has reacted positively to proposals by the Philippines Bureau of Food And Drugs to streamline the registration process for pharmaceutical products and improve patient access to new medicines1,2. When finalised, the proposals are expected to, among other things, amend the existing drug registration guidelines and make compulsory the implementation of the Association of South East Asian Nations’ common technical dossier and common technical requirements as the basic parameters for registering pharmaceutical products.
You may also be interested in...
As companies undergo pharmacovigilance inspections from a growing multitude of regulatory authorities from around the globe, a senior pharmaceutical industry executive discusses how her company has been handling this complex and challenging task.
While inspection interviews can be stressful for drug firms, a Dutch pharmacovigilance inspector reassures companies that any responses made during the process cannot undo any good work they have already done. And they can also correct any wrong answers later on.
The Saudi Food & Drug Authority looks at the number of individual case safety reports (ICSRs) submitted by a company, among other risk-based factors, when drawing up its list for routine pharmacovigilance inspections.